Thomas Yuen spent the final decades of his life funding and promoting stem-cell therapy research, in hopes of finding treatments for chronic diseases like the one that runs in his family. He donated to the University of California, Irvine’s stem research department and spared no expense outfitting his own R&D firm, PrimeGen Biotech, which has been accumulating stem-cell patents since 2004 …. Mr. Yuen immigrated to America and attended community college before transferring to UC Irvine to study electrical engineering. [Subscription required, campus-wide access provided by UCI Libraries. Sign-up here: https://guides.lib.uci.edu/news/wsj] Read More

The Wall Street Journal
The Wall Street Journal